(Q35539740)

8 August 2017

1 reference

title

Diagnosis, treatment and control of Taenia solium cysticercosis (English)

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

12 March 2024

0 references

0 references

3

Robert H Gilman

1 reference

8 August 2017

1

Hector H Garcia

1 reference

Armando Emiliano González

8 August 2017

2

object named as

Armando E. Gonzalez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501993

12 March 2024

author name string

Cysticerosis Working Group in Peru

4

1 reference

8 August 2017

Hector H. Garcia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501993

12 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501993

12 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00001432-200310000-00007

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Current Opinion in Infectious Diseases

12 March 2024

published in

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

411-419

1 reference

Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Selective tomographic imaging of patients with new-onset seizure disorders

12 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Infections in Hispanic immigrants

12 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Psychiatric presentations of non-HIV infectious diseases. Neurocysticercosis, Lyme disease, and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection

12 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Cysticercotic encephalitis: a severe form in young females

12 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.

12 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel

12 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Intramedullary cervical spine cysticercosis

12 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Immunodiagnosis of taeniasis by coproantigen detection.

12 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations

12 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Parenchymal neurocysticercosis: follow-up and staging by MRI

12 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis

12 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis.

12 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

A seroepidemiological study of human cysticercosis in West Cameroon.

12 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA.

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis

12 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Proposed diagnostic criteria for neurocysticercosis

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Niclosamide therapy for tapeworm infections

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis

12 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis

12 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450.

12 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

12 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis

12 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

12 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Pediatric Infectious Disease Journal

12 March 2024

30

22

268

Singhi

2003

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent

12 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Current consensus guidelines for treatment of neurocysticercosis

12 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities.

12 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

High prevalence of calcified silent neurocysticercosis in a rural village of Mexico.

12 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Neurocysticercosis: eradication of cysticercosis is an attainable goal

12 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

12 March 2024

Control of Taenia solium

37

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

Taenia solium oncosphere antigens induce immunity in pigs against experimental cysticercosis

12 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis.

12 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00001432-200310000-00007

12 March 2024

Identifiers

1 reference

8 August 2017

1 reference